NASDAQ: HSCS
Heartsciences Inc Stock

$3.57-0.21 (-5.56%)
Updated Jul 3, 2025
HSCS Price
$3.57
Fair Value Price
$0.13
Market Cap
$3.86M
52 Week Low
$2.36
52 Week High
$5.30
P/E
-0.48x
P/B
2.16x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$0.00
Earnings
-$8.52M
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
2.19
Operating Cash Flow
-$7M
Beta
0.3
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

HSCS Overview

Heart Test Laboratories, Inc., a medical technology company, provides cardiovascular diagnostic devices. The company offers MyoVista wavECG, a resting 12-lead electrocardiograph (ECG) to provide diagnostic information related to cardiac dysfunction, as well as conventional 12-lead resting ECG information. It serves clinics, doctor's offices, urgent care centers, and hospitals. The company was incorporated in 2007 and is headquartered in Southlake, Texas.

Zen Rating

Our proven quant model uses 115 proprietary factors, including AI, to determine HSCS's potential to beat the market

Zen Rating Component Grades

N/A
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.

Industry: Medical Device

Industry Rating
C
HSCS
Ranked
Unranked of 106

Top Ranked Stocks in Industry

Name / TickerPriceZen Rating
$12.35A
$30.28A
$237.55A
View Top Medical Device Stocks

Be the first to know about important HSCS news, forecast changes, insider trades & much more!

HSCS News

Overview

Due Diligence Score

Industry Average (27)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how HSCS scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

HSCS ($3.57) is overvalued by 2,589.45% relative to our estimate of its Fair Value price of $0.13 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
HSCS ($3.57) is not significantly undervalued (2,589.45%) relative to our estimate of its Fair Value price of $0.13 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
HSCS is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more HSCS due diligence checks available for Premium users.

Valuation

HSCS fair value

Fair Value of HSCS stock based on Discounted Cash Flow (DCF)

Price
$3.57
Fair Value
$0.13
Overvalued by
2,589.45%
HSCS ($3.57) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
HSCS ($3.57) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
HSCS is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

HSCS price to earnings (PE)

For valuing profitable companies with steady earnings

Company
-0.48x
Industry
36.28x
Market
30.96x

HSCS price to book (PB)

For valuing companies that are loss-making or have lots of physical asset

Company
2.16x
Industry
4.1x
HSCS is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

HSCS's financial health

Profit margin

Revenue
$0.0
Net Income
-$2.5M
Profit Margin
0%
HSCS's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials

Assets to liabilities

Assets
$5.7M
Liabilities
$3.9M
Debt to equity
2.19
HSCS's short-term assets ($3.63M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
HSCS's short-term assets ($3.63M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
HSCS's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$1.6M
Investing
-$15.7k
Financing
$180.2k
HSCS's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

HSCS vs Medical Device Stocks

TickerZen RatingMarket Cap1d %P/EP/B
HSCS$3.86M-5.56%-0.48x2.16x
AMIX$3.95M-6.58%-0.22x0.49x
XYLO$4.01M-1.07%-0.62x0.22x
VEROD$3.66M-12.88%-0.04x2.04x
TIVCD$3.50M+4.18%-0.30x1.15x

Heartsciences Stock FAQ

What is Heartsciences's quote symbol?

(NASDAQ: HSCS) Heartsciences trades on the NASDAQ under the ticker symbol HSCS. Heartsciences stock quotes can also be displayed as NASDAQ: HSCS.

If you're new to stock investing, here's how to buy Heartsciences stock.

What is the 52 week high and low for Heartsciences (NASDAQ: HSCS)?

(NASDAQ: HSCS) Heartsciences's 52-week high was $5.30, and its 52-week low was $2.36. It is currently -32.63% from its 52-week high and 51.27% from its 52-week low.

How much is Heartsciences stock worth today?

(NASDAQ: HSCS) Heartsciences currently has 1,080,946 outstanding shares. With Heartsciences stock trading at $3.57 per share, the total value of Heartsciences stock (market capitalization) is $3.86M.

Heartsciences stock was originally listed at a price of $170.00 in Jun 15, 2022. If you had invested in Heartsciences stock at $170.00, your return over the last 3 years would have been -97.9%, for an annualized return of -72.41% (not including any dividends or dividend reinvestments).

How much is Heartsciences's stock price per share?

(NASDAQ: HSCS) Heartsciences stock price per share is $3.57 today (as of Jul 3, 2025).

What is Heartsciences's Market Cap?

(NASDAQ: HSCS) Heartsciences's market cap is $3.86M, as of Jul 5, 2025.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Heartsciences's market cap is calculated by multiplying HSCS's current stock price of $3.57 by HSCS's total outstanding shares of 1,080,946.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.